Current trends in clinical pharmacology in the USA.
D000818:Animals; D001215:Asparaginase; D002051:Burkitt Lymphoma / Q000188:drug therapy; D002188:Cannabis; D002273:Carcinogens; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000009:adverse effects; D003494:Cyclamates; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine; D005260:Female; D006801:Humans; D007880:Legislation, Drug; D007938:Leukemia / Q000188:drug therapy; D010600:Pharmacology; D000297:Psychology, Adolescent; D019966:Substance-Related Disorders; D013923:Thromboembolism / Q000139:chemically induced; D014481:United States; D014486:United States Food and Drug Administration; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced
D002273:Carcinogens; D003276:Contraceptives, Oral; D003494:Cyclamates; D003561:Cytarabine; D003520:Cyclophosphamide; D001215:Asparaginase